Intrauterine G-CSF in IUI cycles for women with thin endometrium may improve endometrial thickness and pregnancy rates: A randomized controlled study

在宫腔内人工授精周期中,对子宫内膜薄的女性使用宫腔内粒细胞集落刺激因子(G-CSF)可能改善子宫内膜厚度并提高妊娠率:一项随机对照研究

阅读:1

Abstract

BACKGROUND: Optimum endometrial thickness (ET) which grows in synchrony with growing follicle in stimulated intra-uterine insemination (IUI) cycles, is essential for achieving pregnancy. However, in some women, endometrium is unresponsive and fails to reach optimal thickness. Few studies have explored the role of intrauterine infusion of granulocyte colony-stimulating factor (G-CSF) to improve ET. This study was done to evaluate efficacy of intrauterine G-CSF infusion in improving ET, and pregnancy rates in IUI cycles with thin endometrium. METHODS: In this prospective randomized controlled study, 120 infertile women with thin endometrium (<7 mm) on the day of human chorionic gonadotropin (hCG) trigger were randomized. Study group (60) received 1 ml G-CSF (300 μg), by slow intrauterine infusion using IUI catheter. Control group (60) received 1 ml normal saline as placebo. hCG was administered at 2200 h on same day. ET was reassessed 36 h later by trans-vaginal scan (TVS) before IUI. RESULTS: Twenty-seven (27) of 60 study group patients (45%) achieved optimal ET of ≥7 mm, whereas 19 of 60 control group patients (31.67%) achieved optimal ET. In the study group, 6 of 27 patients (22.22%) had positive urine pregnancy test, versus 3 of 19 patients (15.79%) in control group. Of these 5 patients (18.52%) in the study group and 2 patients (10.53%) in control group continued to have clinical pregnancy. Improved outcomes seen in G-CSF group were not statistically significant. CONCLUSION: Our study suggests that G-CSF might have potential to improve ET and clinical pregnancy rate in women with thin endometrium undergoing IUI.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。